'Undruggable' mutation meets its match: Six-year effort yields first drug to target important cancer gene
In the field of drug design, the protein K-Ras is legendary. It's been on everyone's "target" list for more than 30 years due to its status as the most commonly mutated oncogene in human cancers. Despite ...
Nov 20, 2013
4.8 / 5 (6) | 0 |